KIT and intrahepatic cholangiocarcinoma: Therefore, in the present study, we used CD34 as marker for telocytes, and we also performed CD34/CD31, CD34/c-kit and CD34/α-SMA double immunostaining to clearly distinguish telocytes from endothelial cells, ICC and myofibroblasts, respectively.